Ruth Dekker
Family · Pocatello, IDNPI 1275667685
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,014 of the $10,357 with a category attached, or 67.7%. Neurelis, Inc. accounts for 89.6% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $6,130, more than ten times the $152 reported in 2021. Among family clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $175.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$9K
- Jazz Pharmaceuticals Inc.$748
- Livanova USA, Inc.$176
- UCB, Inc.$75
- SK Life Science, Inc.$43
- Sunovion Pharmaceuticals Inc.$20
- plus $14 from 1 others
What the payments were for
- Speaking & faculty fees$7,01468%
- Travel & lodging$1,72917%
- Food & beverage$1,61416%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 30 | $9,281 |
| Jazz Pharmaceuticals Inc. | 19 | $748 |
| Livanova USA, Inc. | 3 | $176 |
| UCB, Inc. | 3 | $75 |
| SK Life Science, Inc. | 2 | $43 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,357 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 78 | $150,709 |
| ZonegranZonisamide | 15 | $114,555 |
| EpidiolexCannabidiol (Cbd) | 32 | $83,804 |
| LamictalLamotrigine | 55 | $80,123 |
| AptiomEslicarbazepine Acetate | 29 | $53,987 |
| BriviactBrivaracetam | 49 | $52,374 |
| Keppra XrLevetiracetam | 23 | $50,248 |
| Zonisamide | 846 | $48,901 |
| Lacosamide | 473 | $46,490 |
| Levetiracetam | 968 | $44,528 |
| ZonisadeZonisamide | 30 | $43,891 |
| Oxtellar XrOxcarbazepine | 12 | $43,042 |
| NayzilamMidazolam | 29 | $36,696 |
| Carbamazepine ErCarbamazepine | 246 | $34,798 |
| Clobazam | 347 | $31,426 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Briviact, Nayzilam | $75 | $89,06978 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $20 | $53,98729 claims |
| Supernus Pharmaceuticals, Inc.Oxtellar Xr | $14 | $43,04212 claims |
| Neurelis, Inc.Valtoco | $9,281 | $24,58316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 809 family providers in Idaho.
Other family in Pocatello
- Jessicka PricePocatello$11K
- Rebekah LuceroPocatello$7K
- Travis NewsomPocatello$6K
- Stacy JamesPocatello$5K
- Paul BowersPocatello$4K
- Bobbi BullockNampa$609K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Alysha SchlackNampa$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.